<DOC>
	<DOCNO>NCT01651650</DOCNO>
	<brief_summary>Phase IIa , single-centre , open-label , single-arm study , evaluate inspiration profile NEXThaler® device adult asthmatic patient vary degree disease control .</brief_summary>
	<brief_title>An Open Label Placebo Study Assess Inhalation Profile Asthmatic Patients Using Nexthaler® Dry Powder Inhaler ( DPI ) Device</brief_title>
	<detailed_description>The primary objective study assess inspiratory flow profile NEXThaler® device adult asthmatic vary degree disease control . The study plan foresee one visit clinic . At Visit 1 , signature inform consent form , inclusion/exclusion criterion check lung function parameter evaluate . If subject meet inclusion/exclusion criterion , instruct use NEXThaler® . The patient subsequently inhale device inspiration profile measure . A total 40 asthmatic adult ( ≥18 year ) , 20 control stable disease 20 partly control uncontrolled disease accord GINA guideline ( 2011 ) , enrol .</detailed_description>
	<criteria>Clinical diagnosis control , partly control uncontrolled asthma accord GINA guideline ( 2011 ) A cooperative attitude ability use DPIs train proper use NEXThaler® confirm activation training device BAM Significant seasonal variation asthma asthma occur episodic exposure allergen chemical sensitizer History near fatal asthma ( e.g . brittle asthma , hospitalisation asthma exacerbation Intensive Care Unit ) Diagnosis restrictive lung disease Significant unstable medical history and/or treatment cardiac , renal , neurological , hepatic , endocrine disease , laboratory abnormality indicative significant underlying condition , may interfere patient 's safety , compliance , study evaluation , accord investigator 's opinion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>PIF</keyword>
</DOC>